Santiago Ini

Santiago Ini received his PhD in Organic Chemistry from the Faculty of Chemistry at the Technion. From 2000-03 he made a post-doctoral work in Organometallic Chemistry and Imprinting Polymers at UC Berkeley followed by a MBA.
Prior to join to the Technion technology transfer office as a Director of Business Development in Life Science, he played a role as a top manager at the Chemistry Division of Teva Pharmaceutical industry, Enzymotec and Algatechnologies providing innovation and leadership in the life science sector.
Dr. Ini is an author of several scientific articles and more than forty patents. During the last years he dealt with implementations of strategic alliances in the area of Chemicals and Food Additives. He is the founder of Mental Heal, a company that develops a drug for the treatment of schizophrenia and Glaucopharm, a company dealing with the treatment for Glaucoma.